IOVANCE BIOTHERAPEUTICS, INC. Shares Issued, Price Per Share
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Shares Issued, Price Per Share of $9.15 per share as of 2024-02-22, per its 10-K filed 2026-02-24.
Financial Statements › Notes
us-gaap:SharesIssuedPricePerShare · last filed 2026-02-24
- 2024-02-22: Shares Issued, Price Per Share $9.15.
- 2023-07-13: Shares Issued, Price Per Share $7.50.
- 2018-10-31: Shares Issued, Price Per Share $9.97.
- 2018-10-17: Shares Issued, Price Per Share $9.97.
| Period end | Shares Issued, Price Per Share |
|---|---|
| 2024-02-22 | $9.15 10-K · filed 2026-02-24 |
| 2023-07-13 | $7.50 10-K · filed 2026-02-24 |
| 2018-10-31 | $9.97 10-Q · filed 2020-11-05 |
| 2018-10-17 | $9.97 10-Q · filed 2020-05-05 |
| 2018-01-31 | $11.50 10-Q · filed 2020-11-05 |
| 2017-09-25 | $6.50 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |